Status:
COMPLETED
Pharmacogenetic of Salbutamol in Pediatric Asthma Crisis
Lead Sponsor:
Hôpital Necker-Enfants Malades
Conditions:
Asthma
Eligibility:
All Genders
6-16 years
Brief Summary
this study is designed to identify the genetic factors which can be implicated in the salbutamol responsiveness for asthmatic children in pediatric emergency department
Detailed Description
Patients from 6 to 16 years old consulting for an acute asthma exacerbation and receiving a treatment by salbutamol according to the usual care could be recruited.Saliva from patient were collected us...
Eligibility Criteria
Inclusion
- children
- 6-16 years old
- asthmatic patients
- consulting for an exacerbation in a pediatric emergency department
- parental informed consent
Exclusion
- comorbidity
- peak flow no available
- pneumonia
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT02195258
Start Date
November 1 2010
End Date
June 1 2013
Last Update
July 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Necker Enfants Malades Hospital
Paris, France, 75015